<DOC>
	<DOC>NCT00981968</DOC>
	<brief_summary>The purpose of this study is to investigate safety, tolerability and pharmacokinetics of sitaxentan following single and multiple oral administrations of sitaxentan sodium in Japanese healthy subjects.</brief_summary>
	<brief_title>Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects</brief_title>
	<detailed_description />
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Healthy male and/or female subjects between the age of 18 and 55 years, inclusive. Body Mass Index of 17.5 to 33.5 kg/m2, and a total body weight &gt;45 kg. Mean body weight and the body weight range of Western subjects are similar to those of Japanese subjects with a 10% plus and minus error. Pregnant or nursing females; females of childbearing potential who are unwilling or unable to use an acceptable method of contraception.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>